↓ Skip to main content

Cost-effectiveness analysis of current non-mandatory hepatitis B vaccination coverage vs expanding coverage among healthcare workers in Ethiopia

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, October 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness analysis of current non-mandatory hepatitis B vaccination coverage vs expanding coverage among healthcare workers in Ethiopia
Published in
Journal of Pharmaceutical Policy and Practice, October 2022
DOI 10.1186/s40545-022-00458-4
Pubmed ID
Authors

Dinksew Tewuhibo, Getahun Asmamaw, Wondim Ayenew

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer > Senior Lecturer 2 20%
Professor > Associate Professor 1 10%
Unspecified 1 10%
Student > Postgraduate 1 10%
Student > Bachelor 1 10%
Other 0 0%
Unknown 4 40%
Readers by discipline Count As %
Medicine and Dentistry 2 20%
Unspecified 1 10%
Immunology and Microbiology 1 10%
Pharmacology, Toxicology and Pharmaceutical Science 1 10%
Unknown 5 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2022.
All research outputs
#3,333,116
of 23,548,905 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#84
of 432 outputs
Outputs of similar age
#69,105
of 445,237 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#4
of 17 outputs
Altmetric has tracked 23,548,905 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 432 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,237 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.